Carla Adams
Family · Nashville, TNNPI 1528365434
Payments from drug & device makers
Across 51 payments — averaging $108.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$801
- AstraZeneca$772
- Sanofi-aventis U.S. LLC$688
- Abbott$444
- Inspire Medical Systems, Inc.$273
- Amgen$266
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,549100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 7 | $801 |
| AstraZeneca | 8 | $772 |
| Sanofi-aventis U.S. LLC | 6 | $688 |
| Abbott | 3 | $444 |
| Inspire Medical Systems, Inc. | 2 | $273 |
| Amgen(2 entities) | 2 | $266 |
| Bayer | 2 | $239 |
| E.r. Squibb & Sons, L.L.C. | 2 | $236 |
| Neurocrine Biosciences, Inc. | 2 | $224 |
| Johnson & Johnson | 2 | $218 |
| Teva Pharmaceuticals USA, Inc. | 1 | $137 |
| Evoke Pharma, Inc. | 1 | $125 |
| Mylan Specialty L.p. | 1 | $123 |
| Akcea Therapeutics, Inc. | 1 | $117 |
| AbbVie | 1 | $116 |
| Idorsia Pharmaceuticals US Inc | 1 | $115 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $114 |
| Alcresta Therapeutics, Inc. | 1 | $108 |
| Corcept Therapeutics | 1 | $102 |
| Dynavax Technologies Corporation | 1 | $98 |
| Scynexis, Inc. | 2 | $97 |
| Zealand Pharma US, Inc. | 1 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Insulet Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$381
- Ozempic$353
- Kerendia$239
- BREZTRI$238
- FARXIGA$236
- Wegovy$233
- INGREZZA$224
- FREESTYLE LIBRE 3$174
- Inspire Upper Airway Stimulation System$168
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$147
- GIMOTI$125
- CARDIOMEMS$123
- Yupelri$123
- COBENFY$122
- UPLIZNA$120
- TEGSEDI$117
- Erleada$116
- IMBRUVICA$116
- DALVANCE$116
- QUVIVIQ$115
How this compares
$5,549 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $767 |
| Doxycycline Hyclate | 12 | $97 |
Paid to pharmacies, not to this prescriber.
Other family in Nashville
- Tamera ThoenerNashville$254K
- Jennifer WilliamsNashville$213K
- Lori LankfordNashville$148K
- Melissa RikalNashville$144K
- Nicole DelliseNashville$67K
- Lesley BallanceNashville$63K
- Jeffrey WoodsNashville$38K
- Courtney HavillNashville$35K
- Collette UtleyNashville$28K
- Stacy BrownMt Juliet$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.